L-tryptophan powder is a free-form essential amino acid ingredient used in capsules, tablets, powder blends, stick packs, selected foods, and other nutrition products. For B2B buyers, selecting a commercial source requires more than comparing purity percentages.
The approved material must match the intended application, assay basis, impurity limits, particle size, processing conditions, regulatory market, and supplier quality system.
Essencefield supplies L-Tryptophan Powder as a fine white to off-white crystalline powder. Its published standard direction includes a typical assay of at least 98.5% on a dry basis, with project-specific options for particle size, bulk density, contaminants, microbiology, packaging, and documentation. Final requirements should always be confirmed through an approved specification and batch-specific certificate of analysis.
L-Tryptophan Powder at a Glance
| Technical item | Typical buyer reference |
|---|---|
| Ingredient | L-Tryptophan Powder |
| CAS number | 73-22-3 |
| Molecular formula | C₁₁H₁₂N₂O₂ |
| Molecular weight | 204.23 g/mol |
| Appearance | White to off-white crystalline powder |
| Typical source | Microbial fermentation using non-animal feedstock |
| Typical assay | ≥98.5% on a dry basis |
| Common particle size | Fine powder, often around 80 mesh |
| Main commercial grades | Food and dietary supplement grade |
| Core release tests | Identity, assay, optical rotation, related substances, and moisture |
| Safety controls | Elemental contaminants and microbiological limits |
| Processing properties | Particle size, density, flowability, taste, and dispersibility |
The chemical identity, molecular formula, molecular weight, and recognized synonyms can be independently verified through the U.S. National Library of Medicine’s PubChem L-Tryptophan record.
Grades and Regulatory Fit
Terms such as food grade, supplement grade, feed grade, and pharmaceutical grade are meaningful only when connected to an applicable specification and intended use.
A product with a higher stated assay is not automatically the better commercial choice. Buyers must also evaluate impurity controls, analytical methods, physical properties, manufacturing origin, and regulatory suitability.
| Intended application | Main qualification priorities |
| Food manufacturing | Food-standard compliance, assay, contaminants, microbiology, solubility, and labeling |
| Dietary supplements | Identity, purity, strength, COA reliability, supplier qualification, and cGMP controls |
| Animal feed | Production strain, assay, endotoxins, dusting, stability, and authorization |
| Pharmaceutical processing | Named pharmacopoeial standard, related substances, validated methods, and change control |
| Research use | Reagent specification, analytical suitability, and intended-use restrictions |
Food and dietary supplement use
In the United States, 21 CFR 172.320 lists L-tryptophan among amino acids that may be used as nutrients added to food under the conditions defined in the regulation. These conditions address the form of the amino acid, specifications, nutritional purpose, food composition, records, and labeling. The listing should not be interpreted as unrestricted authorization for every food product or use level.
Food buyers should confirm:
- Intended food category and use level
- Applicable compositional standard
- Finished-product serving size
- Elemental contaminant limits
- Microbiological criteria
- Labeling requirements
- Destination-market restrictions
Dietary supplement manufacturers must establish specifications and controls appropriate to ingredient identity, purity, strength, composition, and finished-product quality. FDA’s dietary supplement cGMP compliance guide addresses supplier qualification, representative sampling, specifications, testing, quality-control review, and traceability.
Other regulated applications
Feed-grade, pharmaceutical-grade, and research-grade materials require separate qualification.
An EFSA assessment of a feed additive containing at least 98% L-tryptophan considered not only assay but also the specific Escherichia coli production strain, manufacturing process, impurities, user exposure, target species, and conditions of use. Its conclusions apply to the evaluated product and process rather than every commercial L-tryptophan source. The full assessment is available through the EFSA Journal.
“Pharmaceutical grade” should refer to a named pharmacopoeial monograph, registered specification, or buyer-approved pharmaceutical standard. A laboratory reagent with high chemical purity is not automatically suitable for food, supplement, feed, or pharmaceutical production.
Manufacturing and Process Control
Commercial L-tryptophan powder is commonly produced through microbial fermentation followed by purification.
A simplified process includes:
- Controlled fermentation
- Separation of the production biomass
- Purification and concentration
- Crystallization and drying
- Milling, sieving, testing, and packaging
Essencefield’s published product information describes its standard sourcing direction as fermentation-derived from non-animal feedstock, followed by purification, crystallization, drying, milling, and sieving.
Production-strain review
For regulated or higher-risk projects, the supplier file may need to identify:
- Production microorganism and strain
- Genetically modified or non-GM status
- Control of viable production organisms
- Residual recombinant DNA where relevant
- Fermentation substrates and processing aids
- Purification process and manufacturing location
- Batch-level traceability
This information is particularly important when a regulatory assessment or authorization applies to a defined production strain and manufacturing process.
Process changes
Buyers should require advance notification of material changes to the production strain, manufacturing site, fermentation or purification process, analytical methods, agreed specification, particle-size treatment, packaging, or shelf-life basis.
A process change can affect impurity profiles, color, odor, flowability, solubility, or regulatory status even when the reported assay remains unchanged.
Critical L-Tryptophan Specifications
A purchasing specification should separate core release tests, safety controls, and application-specific physical properties.
Core release tests
| Parameter | Buyer verification | Procurement significance |
| Identification | Method and reference standard | Confirms the supplied substance is L-tryptophan |
| Assay | Test method and calculation basis | Determines formula input and active-content cost |
| Specific optical rotation | Solvent, concentration, temperature, and range | Supports confirmation of the expected L-form |
| Related substances | Named, unknown, and total impurity limits | Controls process by-products and degradation impurities |
| Loss on drying | Method and limit | Affects stability, flow, and dry-basis calculations |
| Residue on ignition | Method and acceptance limit | Indicates inorganic residue |
Safety controls
Food and supplement specifications commonly address:
- Lead
- Arsenic
- Cadmium
- Mercury
- Total plate count
- Yeast and mold
- E. coli
- Salmonella
Separate numerical results for lead, arsenic, cadmium, and mercury provide more useful risk information than one combined “heavy metals” result.
The appropriate limits depend on the destination market, intended intake, finished-product category, serving size, customer requirements, and total exposure from the complete formula.
Application-specific properties
| Property | Potential manufacturing effect |
| Particle-size distribution | Blend uniformity, segregation, dissolution, and dusting |
| Bulk density | Capsule filling, feeder settings, and package volume |
| Flowability | Hopper discharge, dosing accuracy, and line efficiency |
| Moisture or water activity | Caking, stability, and open-container handling |
| Solubility or dispersibility | Beverage clarity, turbidity, and sedimentation |
| Taste and odor | Flavor selection and masking requirements |
| Hygroscopicity | Warehouse stability and resealing requirements |
These properties may not appear on every routine COA, but they can determine whether a chemically compliant material performs consistently in commercial production.
Assay Basis and Cost Comparison
Assay values should identify whether the result is reported:
- As received
- On a dry basis
- On an anhydrous basis
- By HPLC
- By another agreed analytical method
- Against a defined reference standard
Two materials described as 98.5% L-tryptophan may not be directly comparable when one result is reported on a dry basis and the other is reported as received.
A basic active-content comparison can be calculated as:
Assay-adjusted cost = quoted price per kilogram ÷ assay fraction
For example, a powder priced at $10.00/kg with a 98.5% assay has an assay-adjusted cost of approximately $10.15/kg of measured L-tryptophan.
This calculation does not account for impurities, testing, documentation, physical performance, logistics, or batch-rejection risk.
Specific optical rotation supports stereochemical identity. The result is useful only when the supplier states the solvent, concentration, temperature, wavelength, calculation basis, and acceptance range. Optical rotation should complement chromatographic or spectroscopic identification rather than replace it.
Related Substances and Process Impurities
A high total assay does not characterize every low-level impurity. L-tryptophan intended for controlled commercial production may therefore require a related-substances method in addition to an assay test.
Depending on the risk assessment, buyers may request:
- Named impurity limits
- Individual unknown-peak limits
- Total related-substance limit
- Representative HPLC chromatogram
- Method-suitability information
- Residual-solvent statement
- Out-of-specification procedures
- Retained samples
The historical eosinophilia-myalgia syndrome outbreak associated with certain L-tryptophan products demonstrates why this distinction matters. A CDC investigation identified contamination and unusual chemical components in implicated lots associated mainly with one manufacturing source.
This event does not establish that modern L-tryptophan powder generally presents the same risk. Its procurement lesson is that total assay cannot replace controlled manufacturing, impurity profiling, batch traceability, and formal change management.
Formulation and Processing Fit
Chemical compliance does not guarantee acceptable manufacturing performance. Buyers should test the proposed commercial grade in the intended dosage form and process.
Dry-dose applications
Capsules, tablets, powder blends, and stick packs should be evaluated for:
- Particle-size distribution
- Loose and tapped bulk density
- Flowability
- Dust generation
- Blend uniformity
- Segregation risk
- Fill-weight consistency
- Moisture sensitivity
Capsule trials should confirm the required active load, excipient ratio, capsule size, and filling behavior.
Tablet projects should compare direct compression and granulated systems where appropriate. Critical observations include hardness, friability, disintegration, sticking, lubricant compatibility, and surface appearance.
Low-inclusion powder blends may require geometric dilution, pre-blending, controlled addition sequences, defined mixing times, and multi-location sampling.
An available 80-mesh grade should not automatically become the final purchasing specification. Particle size should be approved after testing in the intended formula and production equipment.
Liquid and semi-solid applications
L-tryptophan has limited water solubility, and its behavior depends on pH, concentration, particle size, mixing method, and the complete formulation system. Essencefield’s product information therefore recommends application testing rather than assuming complete dissolution.
Beverage and gummy development should reproduce the actual:
- Ingredient concentration
- Product pH
- Mixing temperature
- Addition sequence
- Agitation conditions
- Mineral and protein content
- Flavor system
- Heat exposure
- Storage conditions
The development target may be complete dissolution, stable dispersion, or acceptable controlled turbidity.
Teams should evaluate sedimentation, haze, taste, odor, color, texture, water activity, and post-process assay. A generic supplier statement that the material is water soluble is not sufficient evidence for a clear ready-to-drink beverage.
Supplier Qualification and COA Review
A practical approval sequence is:
Supplier qualification → Specification approval → COA review → Sample testing → Pilot evaluation → Commercial approval
Essencefield’s raw material quality process connects supplier qualification, specification confirmation, COA verification, incoming inspection, material release, and batch-level traceability.
Manufacturer and document verification
The buyer should establish:
- Original manufacturing site
- Seller or distributor role
- Country of origin
- Batch-number structure
- Certificate holder and scope
- Supply-chain traceability
- Complaint and corrective-action responsibilities
A typical supplier-approval file may include:
- Product specification
- Batch-specific COA
- Technical data sheet
- Safety data sheet
- Country-of-origin statement
- Allergen statement
- GMO statement
- Gluten and vegan declarations
- Packaging specification
- Stability information
- Relevant facility certificates
Essencefield’s testing and certification support covers specifications, COAs, TDS, SDS, third-party testing, and facility-specific certificate review. Document availability depends on the ingredient, manufacturing source, destination market, and agreed project requirements.
COA warning signs
A COA requires further investigation when it contains:
- Specification limits copied into the results column
- Identical numerical results across multiple batches
- No assay calculation basis
- Missing analytical methods
- No individual elemental-contaminant results
- Inconsistent manufacturer or supplier names
- Unexplained changes to methods or specifications
Commercial release should follow a mutually approved purchasing specification rather than a website description or generic typical COA.
Sample and pilot approval
A representative sample should correspond to the proposed commercial manufacturing source, assay, and physical grade.
Testing may include identity, assay, optical rotation, related substances, moisture, elemental contaminants, microbiology, particle size, bulk density, and application-specific dispersibility.
Pilot production should then assess flow, blending, filling, compression, dissolution, sensory impact, yield, finished-product recovery, stability, and cleaning requirements.
An approved reference sample should be retained for comparison with future commercial batches.
Comparing Commercial Offers
The lowest quoted price per kilogram is not always the lowest qualified cost.
| Commercial factor | Buyer decision |
| Grade | Does the material fit the application and destination market? |
| Assay | Is the price normalized for actual active content? |
| Physical form | Does particle size and density fit the manufacturing process? |
| MOQ | Will the quantity create excess inventory or expiry risk? |
| Packaging | Does it protect against humidity and repeated opening? |
| Testing | Is additional independent verification required? |
| Documentation | Are current specifications and declarations available? |
| Lead time | Is the material in stock or production-dependent? |
| Consistency | Are assay, particle size, density, odor, and flow stable? |
| Change control | Will significant changes be communicated before shipment? |
Total qualified cost may include the assay-adjusted price, freight, insurance, import duties, customs clearance, testing, warehousing, inventory financing, production loss, rework, rejected batches, and downtime.
Projects requiring source comparison or alternative specifications can use Essencefield’s ingredient sourcing support to review product options, supplier documentation, traceability, sampling, and commercial supply requirements.
Essencefield L-Tryptophan Supply Information
Buyers can also review the wider amino acid ingredient catalog when comparing related amino acids, premix components, documentation, or formulation options.
Current published L-tryptophan supply references include:
| Commercial item | Published reference |
| Typical assay | ≥98.5% on a dry basis |
| Grade | Food or dietary supplement grade |
| Appearance | Fine white to off-white crystalline powder |
| Typical particle size | Commonly around 80 mesh |
| Source direction | Fermentation-derived from non-animal feedstock |
| Bulk inner packing | Food-grade double PE bags |
| Outer packaging | Carton or fiber drum |
| Common bulk pack | 20 kg or 25 kg |
| Typical shelf life | 24 months when sealed and correctly stored |
| Standard MOQ | Commonly begins from one standard bulk pack |
| Sample support | Available for qualified formulation and QA projects |
| Standard lead time | Commonly 7–15 working days after order and document confirmation |
| Documents | Specification, COA, TDS, SDS, and project-specific declarations |
These figures are standard commercial references rather than universal guarantees. Final assay, test methods, packaging, MOQ, shelf life, lead time, manufacturing source, and certificate scope must be confirmed in the quotation and approved order documents.
Procurement Checklist and Inquiry
Before approving a bulk order, confirm:
| Decision area | Final approval requirement |
| Application | Dosage form and destination market defined |
| Grade | Intended regulatory and commercial use confirmed |
| Specification | Assay, impurities, contaminants, and physical properties approved |
| Supplier | Manufacturing source and traceability verified |
| Documents | Specification, batch COA, TDS, SDS, and declarations accepted |
| Validation | Representative sample and pilot performance approved |
| Commercial terms | Packaging, MOQ, lead time, Incoterm, and shelf life confirmed |
| Continuity | Change control and repeat-order requirements agreed |
To request the current specification, representative COA, sample availability, packaging details, and quotation, submit the intended application, destination market, required grade, target specification, order volume, and document checklist through the Essencefield contact page.
Conclusion
L-tryptophan powder should be selected through an application-specific qualification process rather than a simple comparison of purity and price.
A reliable purchasing decision combines an agreed assay basis, stereochemical identity, impurity control, processing performance, supplier traceability, batch documentation, pilot validation, and total qualified cost. This approach helps procurement, quality, formulation, and production teams approve a commercially suitable and repeatable source.

















